Laurel Wealth Advisors (North Carolina)’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Laurel Wealth Advisors (North Carolina)’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-569	Closed	-$17.8K	–	593
2025 Q4	$17.8K	Buy	+569	New	+$14K	﹤0.01%	430
2025 Q2	–	Sell	-569	Closed	-$8.75K	–	612
2025 Q1	$8.75K	Hold	569	–	–	﹤0.01%	487
2024 Q4	$12.5K	Hold	569	–	–	﹤0.01%	466
2024 Q3	$10.3K	Buy	569 +333	+141%	+$5.83K	﹤0.01%	459
2024 Q2	$3.83K	Buy	+236	New	+$3.63K	﹤0.01%	510

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Laurel Wealth Advisors (North Carolina)'s TEVA Position: Q1 2026 in Review

Laurel Wealth Advisors (North Carolina) sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q1 2026, closing a stake of 569 shares — an estimated $17.8K sold.

Laurel Wealth Advisors (North Carolina) first reported a position in TEVA in Q2 2024 and held it in 5 quarters. The position peaked at $17.8K in Q4 2025. 654 funds tracked by Wall St. Rank hold TEVA as of Q1 2026.

Laurel Wealth Advisors (North Carolina) reported no remaining Teva Pharmaceutical Industries Limited position as of Q1 2026 after selling out during the quarter.
Laurel Wealth Advisors (North Carolina) sold 569 Teva Pharmaceutical Industries Limited shares in Q1 2026, an estimated $17.8K.
Laurel Wealth Advisors (North Carolina) first reported a position in Teva Pharmaceutical Industries Limited in Q2 2024 and held it in 5 quarters.
Laurel Wealth Advisors (North Carolina)'s Teva Pharmaceutical Industries Limited position peaked at $17.8K in Q4 2025.
654 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q1 2026.

Based on Laurel Wealth Advisors (North Carolina)'s 13F filing for Q1 2026, filed 13 May 2026.